Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid YouGov (YOU) by Steve Moore in ShareProphets
- Avoid Seeing Machines Ltd. NPV (DI) (SEE) by Steve Moore in ShareProphets
- Buy Glencore (GLEN) by Bank of America
- Buy BAE Systems (BA.) by Bank of America
- Underperform BAE Systems (BA.) by ODDO BHF
- Buy Conduit Holdings Limited Com Shs (DI) (CRE) by Jefferies
- Buy Barclays (BARC) by UBS
- Market Perform BAE Systems (BA.) by Bernstein
- Hold InterContinental Hotels Group (IHG) by Deutsche Bank
- Neutral Glencore (GLEN) by Goldman Sachs
- Outperform Weir Group (WEIR) by RBC Capital
- Buy Haleon (HLN) by Berenberg
- Neutral Schroders (SDR) by UBS
- Sector Perform Conduit Holdings Limited Com Shs (DI) (CRE) by RBC Capital
- Buy Kier Group (KIE) by John Ficenec in The Times - Tempus
- Avoid Microsaic Systems (MSYS) by Steve Moore in ShareProphets
- Avoid Aptamer Group (APTA) by Steve Moore in ShareProphets
- Avoid Transense Technologies (TRT) by Steve Moore in ShareProphets
- Outperform Linde (0M2B) by Bernstein
- Avoid Boohoo Group (BOO) by Steve Moore in ShareProphets
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,259 open tips for AstraZeneca (AZN)
| Latest Bid : 15,244.00p | Latest Ask : 15,248.00p |
| High Today : 15,428.00p | Low Today : 15,162.00p |
| This Years High : 15,542.00p | This Years Low : 9,667.00p |
| Volume : 446,941 | MKT Cap : £236344M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Outperform | Bernstein | Premium Only | 2025-02-11 06:53:00 11/02/2025 | 30.42% |
| Buy | Goldman Sachs | Premium Only | 2025-02-10 06:14:00 10/02/2025 | 30.15% |
| Hold | DZ Bank | Premium Only | 2025-02-07 16:09:00 07/02/2025 | 31.23% |
| Hold | Jefferies | Premium Only | 2025-01-20 04:36:00 20/01/2025 | -0.42% |
| Buy | Simon Watkins | Premium Only | 2025-01-15 07:20:00 15/01/2025 | 43.43% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 15,244.00p | Latest Ask : 15,248.00p |
| High Today : 15,428.00p | Low Today : 15,162.00p |
| This Years High : 15,542.00p | This Years Low : 9,667.00p |
| Volume : 446,941 | MKT Cap : £236344M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Outperform | Bernstein | Premium Only | 2025-02-11 06:53:00 11/02/2025 | 30.42% |
| Buy | Goldman Sachs | Premium Only | 2025-02-10 06:14:00 10/02/2025 | 30.15% |
| Hold | DZ Bank | Premium Only | 2025-02-07 16:09:00 07/02/2025 | 31.23% |
| Hold | Jefferies | Premium Only | 2025-01-20 04:36:00 20/01/2025 | -0.42% |
| Buy | Simon Watkins | Premium Only | 2025-01-15 07:20:00 15/01/2025 | 43.43% |